IA Trial Radar | ||
|---|---|---|
L'essai clinique NCT06405048 pour Vaccin contre le VPH est pas encore en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici. | ||
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
Retour à la recherche
Université FudanImpact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment 1 200 Vaccin
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'étude' pour voir et discuter des informations sur l'étude dans la langue sélectionnée.
L'essai clinique NCT06405048 est une étude interventionnel pour Vaccin contre le VPH. Son statut actuel est : pas encore en recrutement. Le recrutement est prévu pour commencer le 28 avril 2024, avec un objectif de 1 200 participants. Dirigée par l'Université Fudan, l'étude devrait être terminée d'ici le 30 juin 2024. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 8 mai 2024.
Résumé succinct
The primary objective of this survey experiment study is to measure the impact of a mock-up Chinese fact-checking extension on the ability to dispel HPV and HPV vaccine-related misinformation among parents of middle school girls in China.
Description détaillée
This survey experiment study aims to assess the feasibility and effectiveness of a mock-up Chinese fact-checking extension on improving the ability to identify HPV and HPV vaccine-related misinformation among parents of middle school girls in three economically diverse regions of China. This includes Shanghai megacity, an urban city in Anhui Province, and rural counties in Anhui Province. The participants will be par...Afficher plus
Titre officiel
Evaluating the Feasibility and Effectiveness of a Mock-up Fact-checking Extension to Improve Ability to Debunk HPV Vaccine Misinformation Among Parents of Middle School Girls: A Survey Experiment
Pathologies
Vaccin contre le VPHPublications
Articles scientifiques et travaux de recherche publiés sur cet essai clinique:Autres identifiants de l'étude
- Fact-checking Extension
Numéro NCT
Date de début (réel)
2024-04-28
Dernière mise à jour publiée
2024-05-08
Date de fin (estimée)
2024-06-30
Inscription (estimée)
1 200
Type d'étude
Interventionnel
PHASE
N/A
Statut
Pas encore en recrutement
Mots clés
HPV vaccine
knowledge
misinformation
vaccine confidence
fact-checking extension
knowledge
misinformation
vaccine confidence
fact-checking extension
Objectif principal
Recherche sur les services de santé
Méthode d'allocation
Randomisé
Modèle d'intervention
Parallèle
Masquage
Double aveugle
Bras / Interventions
| Groupe de participants/Bras | Intervention/Traitement |
|---|---|
ExpérimentalMock-up fact-checking extension intervention group Intervention group participants will engage with three modules:
In Module 1, participants will examine six Weibo post screenshots, each featuring a mock-up of a Chinese fact-checking extension. Participants in the intervention group will assess a statement linked to the content of each post, which aligns with predefined HPV vaccine knowledge from section (b). Their response options will be: 1) Correct, 2) Incorrect,...Afficher plus | Mobile Weibo post screenshot with mock-up Chinese fact-checking extension The intervention in this survey experiment involves mobile Weibo post screenshots equipped with a mock-up Chinese fact-checking browser extension. All screenshots are based on actual Weibo posts. The fact-checking content is generated by a Large Language Model (LLM), tailored to relevant knowledge and prompts, and subsequently validated by experts. The Weibo posts cover a range of popular topics known to contain misi...Afficher plus |
Aucune interventionControl group Control group participants will participate in three modules:
In Modules 1 and 2, they will review six and four Weibo post screenshots, respectively, without the mock-up Chinese fact-checking extension. Participants will evaluate statements linked to the content of each post, aligning with predefined HPV vaccine knowledge from section (b). Their response options will be: 1) Correct, 2) Incorrect, or 3) I don't know,...Afficher plus | N/A |
Critère principal d'évaluation
Critère secondaire d'évaluation
| Critères d'évaluation | Description de la mesure | Période |
|---|---|---|
Ability to debunk misinformation | This outcome measures participants' ability to debunk misinformation about the HPV or HPV vaccine. Total debunking scores range from 0 to 10, with higher scores reflecting better debunking skills. | Day 1, in a single survey |
| Critères d'évaluation | Description de la mesure | Période |
|---|---|---|
HPV vaccination intention | Intention to vaccinate daughters against HPV, measured on a five-point Likert scale from 0 ("very unwilling") to 5 ("very willing"). | Day 1, in a single survey |
HPV vaccine confidence | Vaccine Confidence Index (VCI), including confidence on vaccine effectiveness and safety, measured on a five-point Likert scale from 0 ("strongly disagree") to 5 ("strongly agree"). | Day 1, in a single survey |
Tool acceptance | Determines whether participants would like to use a mock-up fact-checking extension when viewing screenshots of Weibo posts. Responses are either Yes (1) or No (0). | Day 1, in a single survey |
User experience of mock-up fact-checking extension | 4 questions about the user experience of a mock-up fact-checking browser extension, measured using a five-point Likert scale from "strongly disagree" to "strongly agree" | Day 1, in a single survey |
Assistant à la participation
Critères d'éligibilité
Âges éligibles
Adulte, Adulte âgé
Âge minimum
18 Years
Sexes éligibles
Tous
Accepte les volontaires en bonne santé
Oui
- Participants must be parents or legal guardians of female students currently enrolled in participating middle school.
- The parent's or guardian's female middle school student must not have received the HPV vaccine, must not have an HPV vaccination appointment scheduled, and must not have any contraindications to receiving the HPV vaccine.
- Participants must be free of mental health disorders or visual/reading disabilities that could prevent their full participation in and completion of the intervention activities.
- Participants must have provided informed consent and expressed a willingness to actively participate throughout the study.
Université Fudan829 essais cliniques actifs à explorerUniversité de Hong Kong335 essais cliniques actifs à explorerPartie responsable de l'étude
Zhiyuan Hou, Investigateur principal, Associate Professor, Fudan University
Contact central de l'étude
Contact: Zhiyuan Hou, PhD, 86+21 33563935, [email protected]
Contact: Leesa Lin, PhD, +852 39103770, [email protected]
2 Centres de l'étude dans 1 pays
Anhui
Chizhou Health Center for Disease Control and Prevention, Chizhou, Anhui, 247100, China
Liubing Gong, MS, Contact, [email protected]
Shanghai Municipality
Jiading District Center for Disease Control and Prevention, Shanghai, Shanghai Municipality, 201800, China
Hui Peng, MS, Contact, [email protected]